Our mission is to make cancer care better for patients, clinicians, and communities. We work at the nexus of research and practice to create, test, and scale solutions to improve health, health care, and health equity for patients with cancer; enhance the patient and clinician experience; and increase care efficiency and value.
Our Initiatives
We are change agents dedicated to designing, testing, scaling and disseminating innovations in cancer care.
Learn more
We are worldwide experts in employing financial and non-financial interventions to nudge patient and clinician behavior in cancer care, informed by lessons from health economics and behavioral economics.
Learn more
We aim to drive high-value cancer care by designing, testing, scaling and evaluating payment models that enhance affordability, access and innovation.
Learn more
We employ a health equity lens across our work, examining and addressing socioeconomic, racial, and ethnic disparities and other systemic barriers to accessing healthcare.
Learn More
We integrate augmented and artificial intelligence into our solutions to predict health outcomes, support decision making, challenge bias, and enhance health equity.
Augmented & Artificial Intelligence
09.28.2021
PC3I is pleased to share our 2020-2021 Impact Report, which shares highlights from our work over the past year to create, test, and scale solutions to some of the most intractable problems in cancer care delivery.
09.21.2021
Dr. Charu Aggarwal will present on her work fully integrating plasma-based next-generation sequencing into clinical pathways to optimize detection of NCCN-recommended biomarkers in patients with newly diagnosed NSCLC.
07.21.2021
PC3I is delighted to welcome the following new additions: Charu Aggarwal, MD, MPH; Christopher D'Avella, MD; Lola Fayanju, MD, MA, MPHS; Ramy Sedhom, MD; Timothy Brown, MD; Mia Djulbegovic, MD, MHS; Nishant Shah, MD; and Michael Tecce, DO.
10.19.2021
Dr. Christine Edmonds and PC3I Faculty Dr. Lola Fayanju share several ways in which Black women experience socioeconomic barriers and systemic biases that impact breast cancer treatment and survival.
09.27.2021
Researchers from the Population-based Research to Optimize the Screening Process (PROSPR) Consortium are working to eliminate disparities in uptake of lung cancer screening.
08.03.2021
A study looking at privately insured patients with cancer found that spending was higher for those having surgery at NCI cancer centers than at community hospitals.